Skip to main content

Table 6 Percent of private sector providers that reportedly received malaria case management training within the last year, supervision within the last year, subsidized anti-malarials and/or malaria RDT, and report caseload data

From: Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand

 

Private for- profit health facility

% (CI)

Pharmacy

% (CI)

Drug store

% (CI)

General retailer

% (CI)

Itinerant drug vendor

% (CI)

Private sector total

% (CI)

Cambodia

N = 318

N = 99

N = 46

N = 39

N = 235

N = 737

 Training on malaria diagnosis

36.6

43.3

16.4

3.2

9.3

23.9

(29.3, 44.6)

(31.9, 55.4)

(7.8, 31.2)

(0.7, 13.8)

(6.3, 13.7)

(19.5, 28.9)

 Training on NTGs

34.8

41.5

15.2

3.2

7.3

22.2

(27.1, 43.3)

(31.0, 52.7)

(6.8, 30.5)

(0.7, 13.8)

(4.7, 11.3)

(17.8, 27.4)

 Supervision or regulatory visit

18.4

14.7

9.4

0.0

2.9

10.6

(13.8, 24.1)

(7.6, 26.5)

(2.5, 29.8)

(1.4, 5.8)

(7.5, 14.7)

 Subsidized anti-malarials

37.9

52.9

12.2

0.0

14.3

26.9

(32.1, 44.1)

(43.2, 62.4)

(6.1, 22.9)

(10.3, 19.5)

(23.0, 31.1)

 Subsidized RDT

40.1

52.1

27.8

0.0

15.0

29.0

(34.2, 46.2)

(43.9, 60.2)

(15.9, 44.1)

(10.6, 20.9)

(25.0, 33.3)

 Report caseload data

32.4

17.2

8.2

0.0

5.9

17.5

(24.2, 41.9)

(9.5, 29.3)

(1.8, 30.1)

(3.0, 11.5)

(12.1, 24.5)

Lao PDR

N = 94

N = 330

N = 6

N = 30

N = 5

N = 465

 Training on malaria diagnosis

36.6

42.8

4.6

3.7

21.0

31.7

(25.5, 49.3)

(33.1, 53.1)

(0.6, 26.1)

(0.6, 19.5)

(2.9, 70.3)

(23.9, 40.7)

 Training on NTGs

23.3

27.7

30.3

3.7

21.0

22.0

(16.4, 31.9)

(21.0, 35.5)

(6.1, 74.5)

(0.6, 19.5)

(2.9, 70.3)

(16.7, 28.4)

 Supervision or regulatory visit

50.2

62.1

16.7

11.5

0.0

46.7

(37.9, 62.5)

(50.4, 72.6)

(3.7, 51.0)

(5.7, 21.9)

(37.7, 56.0)

 Subsidized anti-malarials

41.8

50.4

0.0

2.5

0.0

36.2

(28.8, 56.1)

(39.7, 61.0)

(0.4, 14.5)

(27.9, 45.3)

 Subsidized RDT

40.4

52.0

25.7

2.5

0.0

37.9

(26.7, 55.9)

(40.7, 63.0)

(4.1, 73.5)

(0.4, 14.5)

(29.2, 47.4)

 Report caseload data

65.1

54.5

0.0

2.5

0.0

41.9

(53.4, 75.2)

(42.7, 65.9)

(0.4, 14.5)

(33.2, 51.1)

Myanmara

N = 354

N = 576

N/Ab

N = 1487

N = 508

N = 2925

 Training on malaria diagnosis

22.6

12.1

3.2

4.4

8.0

(17.4, 27.7)

(7.1, 17.0)

 

(1.4, 5.0)

(2.3, 6.4)

(5.9, 10.2)

 Training on NTGs

23.6

9.3

6.4

6.7

9.4

(18.1, 29.1)

(4.9, 13.7)

 

(3.6, 9.3)

(3.4, 9.9)

(6.9, 11.8)

 Supervision or regulatory visit

32.0

16.7

19.2

12.5

19.9

(25.5, 38.6)

(12.7, 20.8)

 

(16.0, 22.3)

(8.6, 16.3)

(17.1, 22.7)

 Report caseload data

40.3

4.7

2.4

7.7

9.4

(31.0, 49.6)

(2.6, 6.9)

 

(1.0, 3.8)

(4.3, 11.1)

(6.7, 12.1)

  1. Providers in outlets that have malaria testing and/or treatment available on the day of the survey or in the past 3 months
  2. a Questions about subsidized anti-malarials and RDT were not asked in Myanmar
  3. b Drug stores do not exist in Myanmar